Dimensional Fund Advisors LP increased its position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 61.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 256,645 shares of the company's stock after purchasing an additional 97,494 shares during the period. Dimensional Fund Advisors LP owned 0.78% of Bowhead Specialty worth $5,756,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of BOW. Polar Capital Holdings Plc grew its stake in shares of Bowhead Specialty by 77.6% in the 4th quarter. Polar Capital Holdings Plc now owns 1,225,000 shares of the company's stock valued at $34,962,000 after buying an additional 535,065 shares during the period. Vanguard Group Inc. raised its position in shares of Bowhead Specialty by 36.7% during the 3rd quarter. Vanguard Group Inc. now owns 1,506,887 shares of the company's stock valued at $40,746,000 after buying an additional 404,199 shares during the period. Gillson Capital LP purchased a new stake in shares of Bowhead Specialty during the 4th quarter valued at approximately $11,317,000. American Family Investments Inc. lifted its holdings in Bowhead Specialty by 6.9% in the second quarter. American Family Investments Inc. now owns 5,023,778 shares of the company's stock valued at $188,542,000 after acquiring an additional 323,017 shares during the last quarter. Finally, Qube Research & Technologies Ltd lifted its holdings in Bowhead Specialty by 286.5% in the third quarter. Qube Research & Technologies Ltd now owns 326,228 shares of the company's stock valued at $8,821,000 after acquiring an additional 241,829 shares during the last quarter.
Analyst Upgrades and Downgrades
Several research firms have issued reports on BOW. UBS Group set a $28.00 target price on Bowhead Specialty in a research note on Thursday, May 21st. Piper Sandler lowered Bowhead Specialty from an "overweight" rating to a "hold" rating and set a $34.00 price target on the stock. in a research note on Monday, August 3rd. Morgan Stanley increased their price target on Bowhead Specialty from $28.00 to $30.00 and gave the stock an "equal weight" rating in a report on Monday, July 6th. Deutsche Bank Aktiengesellschaft downgraded Bowhead Specialty from a "buy" rating to a "hold" rating and set a $34.00 price objective for the company. in a research report on Monday, August 3rd. Finally, Keefe, Bruyette & Woods boosted their price objective on shares of Bowhead Specialty from $34.00 to $36.00 and gave the company an "outperform" rating in a report on Wednesday, July 8th. Two research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $33.00.
Get Our Latest Analysis on Bowhead Specialty
Bowhead Specialty Price Performance
NYSE:BOW opened at $33.46 on Wednesday. Bowhead Specialty Holdings Inc. has a 52 week low of $21.21 and a 52 week high of $35.07. The stock's fifty day moving average is $29.94 and its two-hundred day moving average is $26.51. The stock has a market capitalization of $1.10 billion, a price-to-earnings ratio of 18.09, a price-to-earnings-growth ratio of 1.00 and a beta of -0.11. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31.
Bowhead Specialty (NYSE:BOW - Get Free Report) last posted its earnings results on Monday, August 3rd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.01. The firm had revenue of $163.86 million for the quarter, compared to analyst estimates of $278.69 million. Bowhead Specialty had a return on equity of 14.05% and a net margin of 10.11%. Research analysts anticipate that Bowhead Specialty Holdings Inc. will post 1.99 EPS for the current year.
About Bowhead Specialty
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.